A cheaper chip can still name brain tumor types
Original title: Towards Democratizing CNS Tumor Classification: 10-fold reduction in methylation sequencing cost with the Flongle Flow Cell
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was a small lab test on tumor samples, not yet part of normal care.
The short version
A $100 lab chip matched a $1,000 one at naming brain tumor types.
What was studied. Researchers tested a low cost lab chip called Flongle. It reads DNA from tumor tissue to help name the tumor type. They tried it on 12 brain and spine tumor samples from children.
What they found. The cheap chip costs about $100. The usual chip costs about $1,000, a 10 fold difference. Two computer programs read the results from the cheap chip. Both named the tumor type correctly every time they had enough data to be confident.
What this means, and what it doesn't
What it could mean: This kind of test may cost hospitals much less to run. Over time, that could make fast tumor typing easier for more people to get.
What it doesn't mean: This is not a treatment, and it is not a cure. It is an early lab test of equipment, not a study of patient care. Only 12 samples were used. It does not change the tests or care you get today.
Source: medRxiv (preprint), September 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.